ANN ARBOR, Mich., April 23, 2024 Esperion today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Following the release, management.
Esperion Presents Important New Data from CLEAR Outcomes at globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
– Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event Compared to Placebo – – NEXLETOL Demonstrated Clinical Benefit in.
Esperion Presents Important New Data from CLEAR Outcomes at ACC 24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Esperion Presents Important New Data from CLEAR Outcomes at ACC 24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.